Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Dagnall CL"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-10 z 10
    Tytuł:
    Evaluation of alcohol-free mouthwash for studies of the oral microbiome.
    Autorzy:
    Yano Y; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Vogtmann E; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Shreves AH; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
    Weinstein SJ; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Black A; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Diaz-Mayoral N; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Wan Y; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Zhou W; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Hua X; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle Washington, United States of America.
    Dagnall CL; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Hutchinson A; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Jones K; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Hicks BD; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Wyatt K; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Brotzman M; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Gerlanc N; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Huang WY; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Albert PS; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Wentzensen N; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Abnet CC; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2023 Apr 27; Vol. 18 (4), pp. e0284956. Date of Electronic Publication: 2023 Apr 27 (Print Publication: 2023).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
    MeSH Terms:
    Mouthwashes*/pharmacology
    Microbiota*/genetics
    Humans ; RNA, Ribosomal, 16S/genetics ; Ethanol ; Bacteria/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident.
    Autorzy:
    Morton LM; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. .
    Karyadi DM; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Stewart C; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
    Bogdanova TI; Laboratory of Morphology of the Endocrine System, V. P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine.
    Dawson ET; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.; Nvidia Corporation, Santa Clara, CA 95051, USA.
    Steinberg MK; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA.
    Dai J; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA.
    Hartley SW; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Schonfeld SJ; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Sampson JN; Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Maruvka YE; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
    Kapoor V; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA.
    Ramsden DA; Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.
    Carvajal-Garcia J; Curriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill, NC 27599, USA.
    Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.
    Parker JS; Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.
    Krznaric M; Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London W6 8RF, UK.
    Yeager M; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA.
    Boland JF; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA.
    Hutchinson A; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA.
    Hicks BD; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA.
    Dagnall CL; Cancer Genomics Research Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA.
    Gastier-Foster JM; Nationwide Children's Hospital, Biospecimen Core Resource, Columbus, OH 43205, USA.; Departments of Pathology and Pediatrics, Ohio State University College of Medicine, Columbus, OH 43210, USA.
    Bowen J; Nationwide Children's Hospital, Biospecimen Core Resource, Columbus, OH 43205, USA.
    Lee O; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Machiela MJ; Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Cahoon EK; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Brenner AV; Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.
    Mabuchi K; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Drozdovitch V; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Masiuk S; Radiological Protection Laboratory, Institute of Radiation Hygiene and Epidemiology, National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv 04050, Ukraine.
    Chepurny M; Radiological Protection Laboratory, Institute of Radiation Hygiene and Epidemiology, National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv 04050, Ukraine.
    Zurnadzhy LY; Laboratory of Morphology of the Endocrine System, V. P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine.
    Hatch M; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Berrington de Gonzalez A; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
    Thomas GA; Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London W6 8RF, UK.
    Tronko MD; Department of Fundamental and Applied Problems of Endocrinology, V. P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine.
    Getz G; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Center for Cancer Research and Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA.
    Chanock SJ; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. .
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2021 May 14; Vol. 372 (6543). Date of Electronic Publication: 2021 Apr 22.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Chernobyl Nuclear Accident*
    Mutation*
    Neoplasms, Radiation-Induced/*genetics
    Thyroid Cancer, Papillary/*etiology
    Thyroid Cancer, Papillary/*genetics
    Thyroid Neoplasms/*etiology
    Thyroid Neoplasms/*genetics
    Adolescent ; Adult ; Child ; Child, Preschool ; DNA Copy Number Variations ; Epigenome ; Female ; Gene Expression Profiling ; Genes, ras ; Genetic Variation ; Humans ; Infant ; Iodine Radioisotopes ; Loss of Heterozygosity ; Male ; Middle Aged ; Proto-Oncogene Proteins B-raf/genetics ; RNA-Seq ; Radiation Dosage ; Thyroid Gland/physiology ; Thyroid Gland/radiation effects ; Translocation, Genetic ; Ukraine ; Whole Genome Sequencing ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.
    Autorzy:
    Lin SH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
    Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
    Grünewald TGP; Max-Eder Research Group for Pediatric Sarcoma Biology, Ludwig Maximilians Universität (LMU), Munich, Germany.; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
    Surdez D; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.
    Reynaud S; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Mirabeau O; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Karlins E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
    Rubio RA; Max-Eder Research Group for Pediatric Sarcoma Biology, Ludwig Maximilians Universität (LMU), Munich, Germany.
    Zaidi S; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Grossetête-Lalami S; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Ballet S; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Lapouble E; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Laurence V; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Michon J; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Pierron G; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Kovar H; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
    Kontny U; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Uniklinik RWTH Aachen, Aachen, Germany.
    González-Neira A; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain.
    Alonso J; Unidad de Tumores Solidos Infantiles (IIER-ISCIII) & Centro de Investigación Biomédica en Red de Enfermedades Raras (CB06/07/1009; CIBERER-ISCIII), Instituto de Salud Carlos III, Majadahonda, Spain.
    Patino-Garcia A; Laboratory of Pediatrics, University Clinic of Navarra, Program in Solid Tumors, Center for Applied Medical Research (CIMA) and Navarra's Health Research Institute (IdiSNA), Pamplona, Spain.
    Corradini N; Institute for Paediatric Haematology and Oncology, Leon Bérard Cancer Centre, University of Lyon, Lyon, France.
    Bérard PM; Institute for Paediatric Haematology and Oncology, Leon Bérard Cancer Centre, University of Lyon, Lyon, France.
    Miller J; Information Management Services, Inc., Calverton, MD, United States of America.
    Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
    Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
    Carter BD; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, United States of America.
    Dagnall CL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
    Burdett L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
    Jones K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
    Manning M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
    Wyatt K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
    Zhou W; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
    Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
    Cox DG; Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.
    Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
    Khan J; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America.
    Armstrong GT; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, United States of America.
    Leisenring WM; Cancer Prevention and Clinical Statistics Programs, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
    Bhatia S; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, United States of America.
    Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, United States of America.
    Kulozik AE; Department of Pediatric Oncology, Hematology and Immunology and Hopp Children Cancer Center, University of Heidelberg, Heidelberg, Germany.
    Kriebel J; Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; German Center for Diabetes Research (DZD), München, Neuherberg, Germany.
    Meitinger T; German Research Center for Environmental Health, Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Human Genetics, Technische Universität München, Munich, Germany.
    Metzler M; Department of Paediatrics and Adolescent Medicine, University Hospital of Erlangen, Erlangen, Germany.
    Krumbholz M; Department of Paediatrics and Adolescent Medicine, University Hospital of Erlangen, Erlangen, Germany.
    Hartmann W; Division of Translational Pathology, Gerhard-Domagk Institute of Pathology, University Hospital of Münster, Münster, Germany.
    Strauch K; Institute of Genetic Epidemiology, LMU Munich, Munich, Germany.
    Kirchner T; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.
    Dirksen U; Pediatrics III, West German Cancer Centre, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), Center Essen, Heidelberg, Germany.
    Mirabello L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
    Tucker MA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
    Tirode F; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Morton LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
    Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
    Delattre O; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
    Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2020 Sep 03; Vol. 15 (9), pp. e0237792. Date of Electronic Publication: 2020 Sep 03 (Print Publication: 2020).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genetic Loci*
    Genetic Predisposition to Disease*
    Genetic Variation*
    Germ Cells/*metabolism
    Sarcoma, Ewing/*genetics
    Genome-Wide Association Study ; Humans ; Linkage Disequilibrium/genetics ; Odds Ratio ; Polymorphism, Single Nucleotide/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study.
    Autorzy:
    Wang Y; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Best A; Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Fernández-Torrón R; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Institute Carlos III, Madrid, Spain.; Neuroscience Area, Institute Biodonostia, San Sebastian, Spain.
    Alsaggaf R; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Garcia-Puga M; Neuroscience Area, Institute Biodonostia, San Sebastian, Spain.
    Dagnall CL; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
    Hicks B; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
    Thompson M; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Matheu Fernandez A; Oncology Area, Biodonostia Health Research Institute, San Sebastián, Spain.
    Zulaica Ijurco M; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Institute Carlos III, Madrid, Spain.; Neuroscience Area, Institute Biodonostia, San Sebastian, Spain.
    Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Lopez de Munain A; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Institute Carlos III, Madrid, Spain.; Neuroscience Area, Institute Biodonostia, San Sebastian, Spain.; Department of Neurology, Hospital Universitario Donostia, San Sebastian, Spain.; Department of Neurosciences, Universidad del País Vasco UPV-EHU, San Sebastian, Spain.
    Gadalla SM; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Pokaż więcej
    Źródło:
    Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Jan; Vol. 7 (1), pp. 126-131. Date of Electronic Publication: 2019 Dec 05.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Intramural
    MeSH Terms:
    Leukocytes*
    Myotonic Dystrophy/*genetics
    Telomere Shortening/*genetics
    Adult ; Female ; Humans ; Male ; Middle Aged ; Pilot Projects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Telomere Length Calibration from qPCR Measurement: Limitations of Current Method.
    Autorzy:
    Wang Y; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Alsaggaf R; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Aubert G; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada. .; Repeat Diagnostics Inc., North Vancouver, BC V7M 1A5, Canada. .
    Dagnall CL; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA. .
    Spellman SR; Center for International Blood and Marrow Transplant Research, Minneapolis, MN 55401, USA. .
    Lee SJ; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI 53226, USA. .; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. .
    Hicks B; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA. .
    Jones K; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA. .
    Katki HA; Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Gadalla SM; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Pokaż więcej
    Źródło:
    Cells [Cells] 2018 Oct 24; Vol. 7 (11). Date of Electronic Publication: 2018 Oct 24.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
    Autorzy:
    Ratnasamy V; University Medical Unit, Teaching Hospital Jaffna, Jaffna, Sri Lanka.
    Navaneethakrishnan S; University Medical Unit, Teaching Hospital Jaffna, Jaffna, Sri Lanka.
    Sirisena ND; Human Genetics Unit, Faculty of Medicine, University of Colombo, Kynsey Road, Colombo 8, Sri Lanka.
    Grüning NM; Centogene AG, Schillingallee 68, 18057, Rostock, Germany.
    Brandau O; Centogene AG, Schillingallee 68, 18057, Rostock, Germany.
    Thirunavukarasu K; University Medical Unit, Teaching Hospital Jaffna, Jaffna, Sri Lanka.
    Dagnall CL; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
    McReynolds LJ; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, USA.
    Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, USA.
    Dissanayake VHW; Human Genetics Unit, Faculty of Medicine, University of Colombo, Kynsey Road, Colombo 8, Sri Lanka. .
    Pokaż więcej
    Źródło:
    BMC medical genetics [BMC Med Genet] 2018 May 25; Vol. 19 (1), pp. 85. Date of Electronic Publication: 2018 May 25.
    Typ publikacji:
    Case Reports; Journal Article; Research Support, N.I.H., Intramural
    MeSH Terms:
    Hemizygote*
    Point Mutation*
    Cell Cycle Proteins/*genetics
    Dyskeratosis Congenita/*genetics
    Nuclear Proteins/*genetics
    Adult ; Cell Cycle Proteins/chemistry ; Humans ; Male ; Nuclear Proteins/chemistry ; Pedigree ; Protein Domains ; Sequence Analysis, DNA ; Telomere Homeostasis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays.
    Autorzy:
    Dagnall CL; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA. .; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA. .
    Morton LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.
    Hicks BD; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Li S; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Zhou W; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Karlins E; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Teshome K; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Chowdhury S; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Lashley KS; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.
    Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA.
    Armstrong GT; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA.
    Bhatia S; Department of Population Sciences, City of Hope, Duarte, CA, USA.; Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
    Radloff GA; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
    Davies SM; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
    Tucker MA; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.
    Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD, USA.
    Pokaż więcej
    Źródło:
    BMC genomics [BMC Genomics] 2018 Mar 06; Vol. 19 (1), pp. 182. Date of Electronic Publication: 2018 Mar 06.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
    MeSH Terms:
    Genome, Human*
    Polymorphism, Single Nucleotide*
    DNA/*genetics
    Mouth Mucosa/*metabolism
    Neoplasms/*genetics
    Saliva/*metabolism
    DNA/analysis ; DNA/blood ; Genomics ; Genotype ; Humans ; Neoplasms/blood ; Nucleic Acid Amplification Techniques ; Oligonucleotide Array Sequence Analysis/methods
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurement.
    Autorzy:
    Dagnall CL; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, United States of America.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Hicks B; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, United States of America.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Teshome K; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, United States of America.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Hutchinson AA; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, United States of America.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Gadalla SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, United States of America.
    Khincha PP; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, United States of America.
    Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, United States of America.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
    Savage SA; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, Maryland, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2017 Sep 08; Vol. 12 (9), pp. e0184098. Date of Electronic Publication: 2017 Sep 08 (Print Publication: 2017).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Real-Time Polymerase Chain Reaction*/methods
    Real-Time Polymerase Chain Reaction*/standards
    Telomere/*genetics
    Telomere Homeostasis/*genetics
    DNA/genetics ; DNA/isolation & purification ; Humans ; Reproducibility of Results ; Specimen Handling/methods ; Specimen Handling/standards
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives.
    Autorzy:
    Khincha PP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Dagnall CL; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA. .
    Hicks B; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA. .
    Jones K; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA. .
    Aviv A; Center of Human Development and Aging, Rutgers State University of New Jersey, Newark, NJ 07103, USA. .
    Kimura M; Center of Human Development and Aging, Rutgers State University of New Jersey, Newark, NJ 07103, USA. .
    Katki H; Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Aubert G; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3, Canada. .
    Giri N; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Alter BP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Gadalla SM; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. .
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2017 Aug 13; Vol. 18 (8). Date of Electronic Publication: 2017 Aug 13.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Telomere Homeostasis*
    Dyskeratosis Congenita/*pathology
    Leukocytes/*pathology
    Telomere/*pathology
    Adolescent ; Adult ; Aged ; Blotting, Southern ; Child ; Child, Preschool ; Dyskeratosis Congenita/genetics ; Female ; Flow Cytometry ; Humans ; In Situ Hybridization, Fluorescence ; Leukocytes/metabolism ; Male ; Middle Aged ; Pedigree ; Real-Time Polymerase Chain Reaction ; Telomere/genetics ; Telomere Shortening ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States.
    Autorzy:
    Yang B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, 20892, United States of America.
    Shebl FM; Yale University School of Public Health, New Haven, CT, 06520, United States of America.
    Sternberg LR; Pathology-Histotechnology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21701, United States of America.
    Warner AC; Pathology-Histotechnology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21701, United States of America.
    Kleiner DE; Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, United States of America.
    Edelman DC; Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, United States of America.
    Gomez A; Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, United States of America.
    Dagnall CL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, 20892, United States of America.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, 20892, United States of America.
    Hicks BD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, 20892, United States of America.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, Frederick, MD, 20892, United States of America.
    Altekruse SF; Division of Cancer Control & Population Sciences, National Cancer Institute, Bethesda, MD, 20892, United States of America.
    Hernandez BY; University of Hawaii Cancer Center, Honolulu, HI, 96813, United States of America.
    Lynch CF; University of Iowa College of Public Health, Iowa City, IA, 52242, United States of America.
    Meltzer PS; Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, United States of America.
    McGlynn KA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, 20892, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Nov 23; Vol. 11 (11), pp. e0166828. Date of Electronic Publication: 2016 Nov 23 (Print Publication: 2016).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Carcinoma, Hepatocellular/*pathology
    Liver Neoplasms/*pathology
    Telomere/*metabolism
    Aged ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/mortality ; Demography ; Female ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/mortality ; Male ; Middle Aged ; Multiplex Polymerase Chain Reaction ; Neoplasm Grading ; Neoplasm Staging ; Proportional Hazards Models ; Telomere Shortening
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-10 z 10

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies